ICAM1 and neoplasm: By examining ICAM-1 levels in CD8+ T cells from the spleens and tumors of MC38 tumor-engrafted mice, we found that CD3+ or CD8+ T cells from tumors comprised a greater proportion of the ICAM-1+ population than did those from the spleens (Figure 2A-C).